The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cost description of chemotherapy regimens for the treatment of metastatic pancreas cancer (mPC).
 
Daniel A. Goldstein
No Relationships to Disclose
 
Kavya Krishna
No Relationships to Disclose
 
Christopher Flowers
Consulting or Advisory Role - Algeta ASA; OptumRx; Seagen
Research Funding - Acerta Pharma (Inst); Celgene (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Infinity Pharmaceuticals (Inst); Janssen Oncology (Inst); Onyx (Inst); Pharmacyclics (Inst); Spectrum Pharmaceuticals (Inst); TG Therapeutics (Inst)
Other Relationship - Celgene
 
Bassel F. El-Rayes
Research Funding - AVEO; Bayer; Bristol-Myers Squibb; Kirin Pharmaceuticals; Novartis; Pfizer; Roche; Synta
 
Tanios S. Bekaii-Saab
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Lilly; Regeneron
Research Funding - NCCN; NCI; Oncolytics
Expert Testimony - Helsinn Therapeutics
Other Relationship - Exelixis; Polaris
 
Anne M. Noonan
No Relationships to Disclose